Homocysteine contributes to atherogenic transformation of the aorta in rabbits in the absence of hypercholesterolemia.

Atherosclerosis B vitamins Choline Homocysteine Rabbits

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 23 05 2024
revised: 29 07 2024
accepted: 30 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

Atherosclerosis, the leading cause of cardiovascular disease, cannot be sufficiently explained by established risk factors, including cholesterol. Elevated plasma homocysteine (Hcy) is an independent risk factor for atherosclerosis and is closely linked to cardiovascular mortality. However, its role in atherosclerosis has not been fully clarified yet. We have previously shown that rabbits fed a diet deficient in B vitamins and choline (VCDD), which are required for Hcy degradation, exhibit an accumulation of macrophages and lipids in the aorta, aortic stiffening and disorganization of aortic collagen in the absence of hypercholesterolemia, and an aggravation of atherosclerosis in its presence. In the current study, plasma Hcy levels were increased by intravenous injections of Hcy into balloon-injured rabbits fed VCDD (VCDD+Hcy) in the absence of hypercholesterolemia. While this treatment did not lead to thickening of aortic wall, intravenous injections of Hcy into rabbits fed VCDD led to massive accumulation of VLDL-triglycerides as well as significant impairment of vascular reactivity of the aorta compared to VCDD alone. In the aorta intravenous Hcy injections into VCDD-fed rabbits led to fragmentation of aortic elastin, accumulation of elastin-specific electron-dense inclusions, collagen disorganization, lipid degradation, and autophagolysosome formation. Furthermore, rabbits from the VCDD+Hcy group exhibited a massive decrease of total protein methylated arginine in blood cells and decreased creatine in blood cells, serum and liver compared to rabbits from the VCDD group. Altogether, we conclude that Hcy contributes to atherogenic transformation of the aorta not only in the presence but also in the absence of hypercholesterolemia.

Identifiants

pubmed: 39116783
pii: S0753-3322(24)01128-4
doi: 10.1016/j.biopha.2024.117244
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117244

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Oksana Tehlivets (O)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; Division of General Radiology, Department of Radiology, Medical University of Graz, Graz, Austria. Electronic address: oksana.tehlivets@uni-graz.at.

Gunter Almer (G)

Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

Markus S Brunner (MS)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Margarete Lechleitner (M)

Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.

Gerhard Sommer (G)

Institute of Biomechanics, Graz University of Technology, Graz, Austria.

Dagmar Kolb (D)

Gottfried Schatz Research Center, Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria; Center for Medical Research, Ultrastructure Analysis, Medical University of Graz, Graz, Austria.

Gerd Leitinger (G)

Gottfried Schatz Research Center, Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria.

Clemens Diwoky (C)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Heimo Wolinski (H)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Hansjörg Habisch (H)

Otto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.

Peter Opriessnig (P)

Division of General Neurology, Department of Neurology, Medical University of Graz, Graz, Austria; Division of Pediatric Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

Francesca Bogoni (F)

Institute of Biomechanics, Graz University of Technology, Graz, Austria.

Dominique Pernitsch (D)

Center for Medical Research, Ultrastructure Analysis, Medical University of Graz, Graz, Austria.

Maria Kavertseva (M)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Benjamin Bourgeois (B)

Otto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.

Jelena Kukilo (J)

Institute of Biomechanics, Graz University of Technology, Graz, Austria.

Yuriy G Tehlivets (YG)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Andreas N Schwarz (AN)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Thomas Züllig (T)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Vladimir Bubalo (V)

Division of Biomedical Research, Medical University of Graz, Graz, Austria.

Silvia Schauer (S)

Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.

Andrea Groselj-Strele (A)

Center for Medical Research, Computational Bioanalytics, Medical University of Graz, Graz, Austria.

Gerald Hoefler (G)

Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.

Gerald N Rechberger (GN)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Markus Herrmann (M)

Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

Kathrin Eller (K)

Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.

Alexander R Rosenkranz (AR)

Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.

Tobias Madl (T)

Otto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.

Saša Frank (S)

Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.

Gerhard A Holzapfel (GA)

Institute of Biomechanics, Graz University of Technology, Graz, Austria; Department of Structural Engineering, Norwegian University of Science and Technology, Trondheim, Norway.

Dagmar Kratky (D)

Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.

Harald Mangge (H)

Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

Gerd Hörl (G)

Otto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.

Classifications MeSH